SMRČKA, Martin, Marek VEČEŘA, Lenka RADOVÁ, Simona SIDOROVÁ, František SIEGL, Radim JANČÁLEK, Markéta HERMANOVÁ, Leoš KŘEN, Jiří ŠÁNA and Ondřej SLABÝ. Global profiling of microRNA expression in brain metastases. In Sborník abstrakt – VII. Sjezd Ukrajinské neurochirurgické společnosti. 2021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Global profiling of microRNA expression in brain metastases
Authors SMRČKA, Martin (203 Czech Republic, belonging to the institution), Marek VEČEŘA (703 Slovakia, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Simona SIDOROVÁ (703 Slovakia, belonging to the institution), František SIEGL (203 Czech Republic, belonging to the institution), Radim JANČÁLEK (203 Czech Republic, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Leoš KŘEN (203 Czech Republic, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution).
Edition Sborník abstrakt – VII. Sjezd Ukrajinské neurochirurgické společnosti, 2021.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30212 Surgery
Country of publisher Ukraine
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/21:00120189
Organization unit Faculty of Medicine
Keywords in English brain metastases; microRNA
Tags rivok
Tags International impact
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 3/1/2022 09:53.
Abstract
Brain metastases (BM) are the most common intracranial tumors occurring in 20-40% of adult cancer patients. BM have long received little attention and, in general, symptomatic palliative care has been indicated without attempting to significantly prolong overall survival (OS). The current approach to BM treatment is changing as the incidence increases over time because of more effective treatment of primary tumors prolonging OS, as well as improved imaging to detect smaller asymptomatic BM. Although the survival of patients with BM is generally unfavorable, the prognosis individually varies significantly. Therefore, it would be useful to strengthen prognostic tools with new high-performance molecular markers. Particularly promising are microRNAs (miRNAs), non-coding RNAs with the length of 18-25 nt, which post-transcriptionally regulate gene expression by silencing mRNA targets. They are stable and thus suitable for sequencing and retrospective analyses in FFPE tissues. Although dysregulated expression (DE) and diagnostic potential of miRNAs have been described in tumors, including BM, there is only a handful of studies describing global miRNA expression profiling in BM and their association with OS.
Links
NV18-03-00398, research and development projectName: Rozšíření současných prognostických skórovacích systémů u mozkových metastáz o mikroRNA profilování s cílem individualizace pooperační péče
Investor: Ministry of Health of the CR, Extension of established prognostic scores in brain metastases by microRNA profiling to tailor the post-operative personalized care
PrintDisplayed: 24/7/2024 18:28